NEW YORK (GenomeWeb) – Roche Diagnostics today announced it has signed a definitive Asset Purchase Agreement with AvanSci Bio for all products associated with the high-performance microdissection of slide mounted tissue sections.

The system comprises instrumentation, software, and consumables used by researchers and clinicians to extract specific areas of tissue for subsequent molecular analysis including real-time PCR, microarrays, and sequencing.

Financial and other details of the agreement were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.